Daratumumab (anti-CD38)

Catalog No.A2027 Synonyms: Darzalex

For research use only.
Not for use in humans.

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Quality Control

Choose Selective CD markers Inhibitors

Biological Activity

Description Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.

Protocol

References

Product Details

CAS No. 945721-28-8
Isotype Human IgG1
Source Human
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Daratumumab (anti-CD38) | Daratumumab (anti-CD38) supplier | purchase Daratumumab (anti-CD38) | Daratumumab (anti-CD38) cost | Daratumumab (anti-CD38) manufacturer | order Daratumumab (anti-CD38) | Daratumumab (anti-CD38) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID